Antihypertensive agents
Pro Research Analysisby 
Searched over 200M research papers for "antihypertensive agents"
Antihypertensive Agents: Efficacy, Safety, and Comparative Analysis
Fixed-Dose Combinations (FDCs) of Antihypertensive Agents
Improved Compliance and Persistence
Fixed-dose combinations (FDCs) of antihypertensive agents have been shown to significantly improve patient compliance compared to free-drug combinations. A meta-analysis of 15 studies involving 32,331 patients found that FDCs were associated with better compliance (odds ratio: 1.21)1. Although there was a nonsignificant improvement in persistence with therapy, the trend suggests potential benefits in long-term adherence1.
Blood Pressure Control and Safety
The same meta-analysis indicated that FDCs did not significantly outperform free-drug combinations in lowering systolic and diastolic blood pressure. However, there was a nonsignificant trend towards fewer adverse effects with FDCs (odds ratio: 0.80)1. This suggests that while FDCs may not drastically improve blood pressure control, they could offer a safer profile for patients.
Pharmacological Classes of Antihypertensive Drugs
Mechanisms of Action and Side Effects
Antihypertensive drugs are categorized into several classes, each with distinct mechanisms of action and side effects. The primary classes include beta-blockers, diuretics, angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor antagonists (ARBs), and calcium channel blockers (CCBs)2. Understanding these mechanisms helps tailor treatment to specific types of hypertension and patient profiles.
Comparative Effectiveness in Special Populations
In kidney transplant recipients, CCBs have been found to reduce the risk of graft loss and improve glomerular filtration rate (GFR) more effectively than ACEIs and ARBs3. However, ACEIs and ARBs are associated with a higher risk of hyperkalemia, which necessitates careful monitoring3.
Blood Pressure Variability and Antihypertensive Agents
Impact on Blood Pressure Variability (BPV)
A study comparing different antihypertensive agents found that amlodipine and indapamide sustained release significantly reduced BPV after three months of treatment4. This reduction in BPV was linked to both a decrease in blood pressure and improvements in autonomic nervous system regulation4.
Antihypertensive Agents in Diabetic Nephropathy
Prevention of Microalbuminuria
ACEIs have been shown to significantly reduce the progression to microalbuminuria in patients with diabetes and normoalbuminuria, compared to placebo and calcium antagonists5. This suggests that ACEIs may be particularly beneficial in preventing diabetic nephropathy.
Arterial Stiffness and Antihypertensive Agents
Effects on Arterial Stiffness
A network meta-analysis revealed that while all antihypertensive agents effectively reduce systolic blood pressure, they do not significantly differ in their impact on arterial stiffness, as measured by pulse wave velocity (PWV)6. However, ACEIs and ARBs were found to be more effective in reducing central arterial hemodynamics compared to older agents like diuretics and beta-blockers10.
Adverse Events and Treatment Discontinuation
Tolerability and Discontinuation Rates
Different classes of antihypertensive drugs have varying profiles regarding adverse events and treatment discontinuation. ARBs were the only class that did not significantly increase discontinuations due to adverse events compared to placebo, making them a more tolerable option for long-term treatment7.
Sexual Function and Antihypertensive Agents
Impact on Sexual Health
Among first-line antihypertensive agents, captopril was found to have the least impact on sexual function in male hypertensive patients, compared to atenolol, trichloromethiazide, and slow-release nifedipine8. This highlights the importance of considering sexual side effects when prescribing antihypertensive medications.
Conclusion
Antihypertensive agents vary widely in their mechanisms of action, efficacy, and side effect profiles. Fixed-dose combinations improve compliance but show nonsignificant benefits in blood pressure control. ACEIs and ARBs are effective in preventing diabetic nephropathy but require monitoring for hyperkalemia. CCBs are preferred in kidney transplant patients for reducing graft loss. Understanding these nuances helps in optimizing hypertension management tailored to individual patient needs.
Sources and full results
Most relevant research papers on this topic
Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents: A Meta-Analysis
Fixed-dose combinations of antihypertensive agents significantly improve compliance and show nonsignificant beneficial trends in blood pressure and adverse effects compared to free-drug combinations.
Meta-Analysis
Highly CitedAntihypertensive drugs
Antihypertensive drugs come in various classes, each with a unique mechanism of action and limited side effects, making them effective treatments for various types of hypertension.
Highly CitedComparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis.
Calcium channel blockers are the preferred first-step antihypertensive agents in kidney transplant patients due to their improved graft function and reduced graft loss, while no definite patient or graft survival benefits are associated with RAS inhibitor use.
Meta-AnalysisEffect of Antihypertensive Agents on Blood Pressure Variability: The Natrilix SR Versus Candesartan and Amlodipine in the Reduction of Systolic Blood Pressure in Hypertensive Patients (X-CELLENT) Study
Amlodipine and indapamide sustained release treatment significantly reduces blood pressure variability, potentially due to lowering blood pressure or improving autonomic nervous system regulation.
RCT
Large Human Trial
Rigorous JournalHighly CitedAntihypertensive agents for primary prevention of diabetic nephropathy.
ACE inhibitors significantly reduce the risk of developing microalbuminuria in normoalbuminuric patients with diabetes, independent of baseline blood pressure, renal function, and type of diabetes.
Meta-AnalysisHighly CitedImpact of antihypertensive agents on arterial stiffness in hypertensive patients.
Antihypertensive agents effectively reduce systolic blood pressure, but not arterial stiffness, in hypertensive patients.
Meta-AnalysisRigorous JournalEffects of blood-pressure-lowering treatment in hypertension: 9. Discontinuations for adverse events attributed to different classes of antihypertensive drugs meta-analyses of randomized trials
All classes of blood pressure-lowering drugs increase treatment discontinuations for adverse events, except for angiotensin receptor blockers, with discontinuations related to treatment often accompanying antihypertensive agents.
Meta-Analysis
Very Rigorous JournalHighly CitedEffects of first‐line antihypertensive agents on sexual function and sex hormones
First-line antihypertensive agents have different effects on sexual function, with captopril showing some advantages in terms of sexual life quality compared to other agents.
RCTHighly CitedBlood pressure treatment levels and choice of antihypertensive agent in people with diabetes mellitus: an overview of systematic reviews
Antihypertensive treatment is effective for people with type 2 diabetes and blood pressure over 140 mmHg, regardless of the major antihypertensive drug classes.
Systematic ReviewVery Rigorous JournalAntihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials
Newer antihypertensive agents, such as RAS inhibitors and CCBs, are significantly more effective than older agents in reducing central arterial hemodynamics.
Meta-Analysis